Gunnar Kaufmann
Plus aucun poste en cours
Fortune : 42 624 $ au 31/03/2024
Profil
Gunnar F.
Kaufmann worked as Senior VP-Immunotherapy & Head-Research at Sorrento Therapeutics, Inc. from 2012 to 2019.
He then worked as Chief Scientific Officer at Oncternal Therapeutics, Inc. from 2019 to 2023.
Kaufmann holds a doctorate degree from The Scripps Research Institute, an undergraduate degree from Philipps University of Marburg, and a graduate degree from the University of Greifswald.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/06/2023 | 4 736 ( 0,16% ) | 42 624 $ | 31/03/2024 |
Anciens postes connus de Gunnar Kaufmann
| Sociétés | Poste | Fin |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 14/06/2023 |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2019 |
Formation de Gunnar Kaufmann
| The Scripps Research Institute | Doctorate Degree |
| Philipps University of Marburg | Undergraduate Degree |
| University of Greifswald | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
